EUVIMEDEUVIMED entdecken
Crossref

Five‐Year Follow‐Up of Unilateral Focused Ultrasound Subthalamotomy for Parkinson's Disease

Elena Natera-Villalba iD, Raúl Martínez-Fernández iD, Tamara Jiménez-Castellanos iD, Rafael Rodríguez-Rojas iD, Marta Del Álamo iD, Jose A Pineda-Pardo iD, Carmen Gasca-Salas iD, Michele Matarazzo iD, Fernando Alonso-Frech, Jose A Obeso

Movement Disorders · 2026

DOI: 10.1002/mds.70307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Elena Natera-Villalba und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro Integral de Neurociencias AC (HM CINAC), Hospital Universitario HM Puerta del Sur, Madrid, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Subthalamic Nucleus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Unilateral focused ultrasound subthalamotomy (STN‐FUS) improves motor features of Parkinson's disease (PD) for up to 3 years.

Objectives

To assess the efficacy of unilateral STN‐FUS in PD 5 years post‐procedure.

Methods

Prospective, open‐label study including PD patients treated with STN‐FUS. Primary outcome: change from baseline in the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III) off‐medication for the treated side. Secondary outcomes: global motor state, motor complications, functional disability, quality of life, medication, and safety.

Results

Forty‐five patients were included; 32 completed 5 years of follow‐up. While off‐medication, the MDS‐UPDRS‐III on the treated side showed 54% improvement from baseline (19.0 [95% CI 17.9–20.1] to 8.8 [7.5–10.1], P < 0.001). The total MDS‐UPDRS‐III was reduced by 27% (37.1 [34.9–39.3] to 27.1 [24.3–29.9], P < 0.001). At 5 years, motor complications, quality of life, and functional disability were equivalent to baseline. Levodopa equivalent daily dose (LEDD) increased from 739.2 (650.1–828.4) to 1053.3 (946.3–1160.3) milligrams ( P < 0.001). Mild‐to‐moderate levodopa‐induced dyskinesias (n = 7) were reported. No late adverse events occurred.

Conclusion

Unilateral STN‐FUS for PD may provide sustained motor benefits after 5 years. © 2026 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseSubthalamic NucleusHumansFemaleFollow-Up StudiesMiddle AgedMaleAgedTreatment OutcomeQuality of LifeProspective StudiesDeep Brain StimulationAntiparkinson Agents

Substanzen

Antiparkinson Agents

Autor:innen und Institutionen

  • Centro Integral de Neurociencias AC (HM CINAC), Hospital Universitario HM Puerta del Sur, Madrid, Spain.
  • PhD Program Medicina y Cirugía, Escuela de Doctorado, Universidad Autónoma de Madrid, Madrid, Spain.
  • Instituto Carlos III, CIBERNED, Madrid, Spain.

ORCID-Profile: Elena Natera-Villalba, Raúl Martínez-Fernández, Tamara Jiménez-Castellanos, Rafael Rodríguez-Rojas, Marta Del Álamo, Jose A Pineda-Pardo, Carmen Gasca-Salas, Michele Matarazzo

Zitieren

APA

Natera-Villalba, E., Martínez-Fernández, R., Jiménez-Castellanos, T., Rodríguez-Rojas, R., Del Álamo, M., Pineda-Pardo, J. A., Gasca-Salas, C., Matarazzo, M., Alonso-Frech, F., & Obeso, J. A. (2026). Five‐Year Follow‐Up of Unilateral Focused Ultrasound Subthalamotomy for Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70307

Vancouver

Natera-Villalba E, Martínez-Fernández R, Jiménez-Castellanos T, Rodríguez-Rojas R, Del Álamo M, Pineda-Pardo JA, et al. Five‐Year Follow‐Up of Unilateral Focused Ultrasound Subthalamotomy for Parkinson's Disease. Movement Disorders. 2026. doi:10.1002/mds.70307

BibTeX
@article{NateraVillalba2026,
  author = {Natera-Villalba, Elena and Martínez-Fernández, Raúl and Jiménez-Castellanos, Tamara and Rodríguez-Rojas, Rafael and Del Álamo, Marta and Pineda-Pardo, Jose A and Gasca-Salas, Carmen and Matarazzo, Michele and Alonso-Frech, Fernando and Obeso, Jose A},
  title = {Five‐Year Follow‐Up of Unilateral Focused Ultrasound Subthalamotomy for Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2026},
  doi = {10.1002/mds.70307}
}
Kostenlos starten →